India’s National Pharmaceutical Pricing Authority announced steep cuts to dozens of anti‑cancer medicines, yet health activists say the measures fall short of ensuring true affordability.
India’s National Pharmaceutical Pricing Authority announced steep cuts to dozens of anti‑cancer medicines, yet health activists say the measures fall short of ensuring true affordability.